⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
AI Visibility Scorecard
Developing medication for rare dermatologic disorders
biomendics.com · Healthcare
Somewhat visible. AI bots can read Developing medication for rare dermatologic disorders, but it is missing the structured signals that push citation rate above competitors.
AI engines read this profile 3 times
Amazon Alexa · Claude
#225,081 of 852,236 in Healthcare for AI visibility
5.3
/10
AEO Score
About Developing medication for rare dermatologic disorders
from our crawl and measurement
"BioMendics is developing liquid crystal medication for patients with rare dermatologic disorders. Their lead clinical program is focused on epidermolysis bullosa simplex. Learn more." That is how Developing medication for rare dermatologic disorders introduces itself. Its AI visibility score is 5.3 out of 10: the engines can find it, but they do not have much to hold on to.
Our crawl found a sitemap. It is missing structured data describing the business, an llms.txt file and a heading structure that lays out what it offers.
AI crawlers have visited 2 times in our tracking, including ClaudeBot (Anthropic) and AmazonBot (Alexa AI).
The 6 signals AI reads
Higher is better · 0-10
Structured Data
1
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
7
Clear headings and answer-style content.
Entity Clarity
5
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
3
Experience, Expertise, Authority, Trust markers.
Technical AEO
7
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
5
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
8
Inbound links from other sites.
Domain Authority
1
Established authority for your domain.
Reference Presence
0
Not in AI knowledge graphs yet.
News & Press
1
Press and news coverage.
Community
0
No community discussion yet.
Social Mentions
0
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 5.3/10, Developing medication for rare dermatologic disorders has a working base to build on - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for Developing medication for rare dermatologic disorders
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Developing medication for rare dermatologic disorders.
Source & Attribution
Scored by Engagemii on August 1, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/biomendics
Cite this score: Engagemii (2026). "AEO Score for Developing medication for rare dermatologic disorders." Retrieved from https://engagemii.com/aeo/brands/biomendics
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform